Article Details

As Organon charts post-spinoff future, Merck's $9B cash infusion could fund big M&A score

Retrieved on: 2021-05-04 21:11:15

Tags for this article:

Click the tags to see associated articles and topics

As Organon charts post-spinoff future, Merck's $9B cash infusion could fund big M&A score. View article details on HISWAI: https://www.fiercepharma.com/pharma/organon-lays-out-its-plan-to-investors-while-spinoff-could-lead-to-a-big-m-a-score-for-merck

Excerpt

With sales for Merck's women's health, biosimilar and older meds sagging in recent years, the drugmaker is gearing up to jettison those offerings in its ...

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up